Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
acetylcholine receptor
acetylcholine receptor antibody
acute intermittant porphyria
adverse drug reaction
agammaglobulinemia
ageusia
algorithm
alveolar hypoventilation
aminoglycoside
aminopyridine, 4
amphiphysin antibodies
ampicillin
amyotrophic lateral sclerosis
amyotrophic lateral sclerosis, myasthenic syndrome with
ANA
anesthesia, general
anesthesia, local
anosmia
anti Hu antibody
anti MAG antibodies
anti Ri antibody
anti Yo antibody
antiarrhythmic drugs
antibiotics
antibiotics, neurologic complications with
antibodies to voltage-gated calcium channels
anticholinergic drugs
anticholinergic drugs, side effects of
anticholinesterase
anticonvulsants
anticonvulsants, untoward effects of
apnea
areflexia
arm weakness
artane
atypical
autoantibodies
autoimmune disease
autonomic dysfunction
autonomic neuropathy
azathioprine
beta adrenergic blocker
Bielschowsky head tilt test
botulism
brachial neuritis
burning paresthesia
calcium antagonist
calcium antagonist, side effects of
cancer associated myopathy
carcinoid tumor
carcinoma
carcinoma of breast
carcinoma of lung
carcinoma of ovary
cardiomyopathy
cardiotoxicity
CAT scan, chest
cerebellar degeneration
cerebellar lesion
cerebellum
cerebrospinal fluid, elevated protein of
cerebrospinal fluid, gammaglobulin of
cerebrospinal fluid, oligoclonal IgG in
chemotherapy, CNS treatment and complications with
children
Chinese paralytic syndrome
chloroquine
chlorpromazine
chronic progressive external ophthalmoplegia
ciguatera poisoning
ciprofloxacin
citrate
Clinical Pathologic Conference(C.P.C.)
cocaine
collapsin response mediator protein 5 IgG
comorbidities
complications
congenital myasthenic syndromes
constipation
contactin associated protein like 2 antibodies
contrast agents, neurotoxicity of
conversion reaction
cranial nerve palsies
cranial neuropathy
creatine phosphokinase(CPK)elevated
critical care unit
cyclosporine
deafness
demyelinating disease
dermatomyositis
developmental retardation
diaphragmatic paralysis
dilantin
dilantin, toxicity
diphtheria
diplopia
diplopia, transient
diplopia, vertical
drug abuse
drug abuse, neurologic complications of
drug induced neurologic disorders
dysarthria
dysphagia
dysphonia
electromyogram
electromyogram, decremental response
electromyogram, incremental response
electron microscopy
encephalitis
encephalitis, autoimmune
encephalitis, brainstem
encephalitis, paraneoplastic
encephalomyelitis
encephalopathy
epidemiology of neurology
erythromycin
exercise
exercise-related muscle strength increase
eye movement, disorders of
face, numbness of
facial nerve palsy
facial weakness
familial
fasciculation
fatigue
fish poisoning
fluoroquinolones
fontanel, bulging
gait disorder
gammaglobulin therapy, intravenous
gaze palsy
gaze palsy, horizontal
gaze palsy, supranuclear
gaze palsy, vertical
gene mutation
genetic neurologic disorders
genetic testing
Graves ophthalmopathy
Guillain Barre syndrome
Guillain Barre syndrome, differential diagnosis of
heat intolerance
heavy metal intoxication
HLA
Hodgkin's disease
Hodgkin's disease, neurologic involvement with
hormone replacement
hot bath test
H-reflex testing
hypercapnia
hypocalcemia
hyporeflexia
iatrogenic neurologic disorders
immune checkpoint inhibitors
immune-related adverse events
immunologic disease
immunology and the nervous system
immunosuppressive agents
immunotherapy
impotence
interferon
internuclear ophthalmoplegia
ipilimumab
Kearns-Sayre syndrome
leg weakness, bilateral
leucine rich glioma inactivated 1 antibodies
level of consciousness, decreased
levonorgestrel
lid abnormalities
lid closure, weakness of
lid twitch
limbic encephalitis
lipoprotein receptor-related protein 4
lithium
magnesium salts
malignancy screen
malignancy, occult
Mary Walker phenomenon
melanoma, malignant
mestinon
migraine
misdiagnosis
mitochondrial disease
mitochondrial encephalomyopathy
monoclonal antibodies
mortality
motor neuron disease
MRI
MRI, abnormal
multiple sclerosis
muscle biopsy
muscle cramp
muscle pain
muscle relaxant
muscle strength, testing
muscle weakness
muscle weakness, proximal
muscle weakness, sudden onset of
muscular dystrophy
MuSK antibodies
myasthenia gravis
myasthenia gravis, classification
myasthenia gravis, cold test for
myasthenia gravis, congenital
myasthenia gravis, diagnosis
myasthenia gravis, differential diagnosis
myasthenia gravis, drug induced
myasthenia gravis, etiology of
myasthenia gravis, exacerbation
myasthenia gravis, familial incidence of
myasthenia gravis, misdiagnosis of
myasthenia gravis, neonatal
myasthenia gravis, neuromuscular junction in
myasthenia gravis, ocular
myasthenia gravis, paraneoplastic
myasthenia gravis, passive transfer of
myasthenia gravis, presenting manifestations
myasthenia gravis, prognosis of
myasthenia gravis, receptor site in
myasthenia gravis, sensory loss with
myasthenia gravis, seronegative
myasthenia gravis, thymectomy in
myasthenia gravis, treatment of
myasthenia gravis, unmasked
myasthenia gravis, variants
myasthenic crisis
myasthenic syndrome
myasthenic syndrome, treatment of
myocarditis
myopathy
myopathy, mitochondrial
myopia
myositis
narcolepsy
nasal speech
neck weakness
nerve conduction studies
neuroendocrinology
neuroleptic
neurologic complications of, systemic cancer
neurologic disease
neurologic disease, diagnoses of
neurologic disease, multifocal
neurologic examination
neurologic history
neurologic signs
neurologic symptoms
neuromuscular blockade
neuromuscular disease, electrodiagnosis of
neuromuscular junction
neuromuscular junction, abnormality of
neuromyelitis optica (Devic's disease)
neuronal cell surface antigen
neuronopathy, sensory
neuroophthalmology
neuropathy
neuropathy, acute
neuropathy, diphtheritic
neuropathy, iatrogenic
neuropathy, medication induced
neuropathy, paraneoplastic
neuropathy, peripheral
neurotoxic
neurotoxin
nicotine
nivolumab
NMDA antagonists
ocular motility, disorders of
onconeural antibodies
ophthalmoplegia
opsoclonus-myoclonus syndrome
optic neuritis
oral contraceptives
orbicularis oculi muscle
ototoxicity
paraneoplastic cerebellar degeneration
paresthesias
Parkinson disease
peek sign
pembrolizumab
penicillamine
peripheral nerve, lesion of
phenothiazine
plasmapheresis
plasmapheresis, complications of
pleocytosis of cerebrospinal fluid
POEMS syndrome
polymyositis
polyneuropathy, chronic inflammatory demyelinating
porphyria
postoperative neurologic complications
practice guidelines
pregnancy, neurologic complications in
premarin
procainamide
progesterone
prognosis
progressive neurologic disorder
propranolol
prostigmine
pseudointernuclear ophthalmoplegia
pseudomyasthenia
psychosis
ptosis
ptosis, alternating
ptosis, bilateral
ptosis, unilateral
Purkinje cell
quality of life
quinidine
quinine
ragged-red fibers
Red flags
remote effect of cancer on the nervous system
renal failure
repetitive nerve stimulation
respiratory depression
respiratory failure
respiratory paralysis, pharmacologic
retinopathy
review article
rheumatoid arthritis, neurologic complications of
rituximab
saccadic eye movements
saccadic eye movements, abnormal
screening
seizure
sensory loss
seronegative
shell fish poisoning
single-fiber electromyography
sleep
sleep apnea
spinal cord, injury of
steroid
steroid therapy, CNS treatment and complications with
superior oblique myokymia
superior oblique palsy
systemic lupus erythematosus
tensilon test
tensilon test, false positive
tetanus antitoxin
third nerve palsy
thymectomy
thymic hyperplasia
thymoma
thymus and neuromuscular function
thyroiditis
thyrotoxicosis
tick paralysis
timolol
tinnitus
treatment of neurologic disorder
trochlear nerve palsy
verapamil
vertigo
viral infection
vision, blurred
visual loss
weakness
weakness, end of day
weakness, fatiguable
weakness, generalized
weakness, progressive
weakness, proximal
weight loss
Wernicke's encephalopathy
wheelchair
workup
xerostomia
Showing articles 0 to 50 of 2789 Next >>

Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum
Ann Neurol 87:659-669, Dubey, D.,et al, 2020

Neuromuscular Adverse Events Associated with Anti-PD-1 Monoclonal Antibodies
Neurol 92:663-674, Johansen, A.,et al, 2019

A Child with Delayed Motor Milestones and Ptosis
Neurol 88:e158-e163, Ghosh, P.S., 2017

Myasthenia Gravis
NEJM 375:2570-2581, Gilhus, N.E.,et al, 2016

Mechanisms, Causes, and Effects of Hypercapnia
UptoDate Dec, Feller-Kopman, D.J. & Schwartzstein, R.M., 2016

Paraneoplastic Neurological Syndromes
Clin Exp Immunol 175:336-348, Leypoldt, F. & Wandinger, K.-P., 2014

Does This Patient Have Myasthenia Gravis?
JAMA 293:1906-1914, Scherer,K.,et al, 2005

Paraneoplastic Syndromes Involving the Nervous System
NEJM 349:1543-1554, Darnell,R.B. &Posner,J.B., 2003

Neuroendocrine Lung Tumors and Disorders of the Neuromuscular Junction
Neurol 52:1490-1491, Burns,T.M.,et al, 1999

Binocular Vertical Diplopia
Mayo Clin Proc 73:55-66, Brazis,P.W.&Lee,A.G., 1998

Fluoroquinolone Antibiotics Block Neuromuscular Transmission
Neurol 50:804-807, Sieb,J.P., 1998

Drugs and Myasthenia Gravis, An Update
Arch Int Med 157:399-408, Wittbrodt,E.T., 1997

Exacerbation of Myasthenia Gravis Associated with Cocaine Use
Neurol 46:271-272, Daras,M.,et al, 1996

Myasthenic Symptoms in Patients with Mitochondrial Myopathies
Muscle & Nerve 18:1338-1340995., Forestier,N.L.,et al, 1995

Myasthenic Symptoms in Patients with Mitochondrial Myopathies
Muscle & Nerve 18:1338-1340, LeForestier,N.,et al, 1995

Myasthenia Gravis
NEJM 330:1797-1810, Drachman,D.B., 1994

Clinicopath Conf
Small Cell CA (of lung) with Lambert-Eaton Myasthenic Syndr, Case 32-1994, NEJM 331:528-5354., , 1994

Ocular Myasthenia Gravis
J Natl Med Assoc 85:681-684, March,G.A.&Johnson,J.N., 1993

Differential Diagnosis of Guillain-Barre Synd, In Guillain-Barre Synd
Thieme Med Publ, Ch 3, p 42993., Parry,G.J., 1993

Aggravation of Myasthenia Gravis by Erythromycin
J Pediatr 119:155-156, Absher,J.R.&Bale,J.F., 1991

Myasthenia Gravis Unmasked by Cocaine Abuse
NEJM 325:892, Berciano,J.,et al, 1991

Aggravation of Myasthenia Gravis by Erythromycin
Ann Neurol 28:577-579, May,E.F.&Calvert,P.C., 1990

Citrate-Induced Impairment of Neuromuscular Transmission in Human and Experimental Autoimmune Myasthenia Gravis
Ann Neurol 27:328-330, Wirguin,I.,et al, 1990

Neuromuscular Blockade
Lancet 335:382-384, , 1990

Adverse Drug Effects on Neuromuscular Transmission
Semin Neurol 10:89-102, Howard,J.F., 1990

The Lambert-Eaton Myasthenic Syndrome, A Review of 50 Cases
Brain 111, 577-5961988., O'Neill,J.H.,et al, 1988

Parkinson's Disease & Myasthenia Gravis:Adverse Effect of Trihexyphenidyl on Neuromuscular Transmission
Neurol 37:832-833, Ueno,S.,et al, 1987

Worsening of Myasthenia Gravis with Timolol Maleate Eyedrops
Ann Neurol 17:211-212, Verkijk,A., 1985

The Neurotoxicity of Antibacterial Agents
Ann Int Med 101:92-104, Snavely,S.R.,et al, 1984

Myasthenia Gravis & Myasthenic Syndromes
Ann Neurol 16:519-534, Engel,A.G., 1984

Procainamide-Induced Myasthenia-like Weakness in a Patient with Peripheral Neuropathy
Arch Neurol 38:378-379, Niakan,E.,et al, 1981

Ultrastructural Localization of Ach Receptor at the Motor Endplate:MG & Other Neuromuscular Dis
Neurol 30:1203-1211, Tsujihata,M.,et al, 1980

Single-fiber Electromyography in Myasthenia Gravis
Neurol 29:68-76, Sanders,D.B.,et al, 1979

Disorders of Neuromuscular Transmission Caused by Drugs
NEJM 301:409-413, Argov,Z.,et al, 1979

Content of Acetylch Receptor & Antib Bound to Receptor in Myasth Gravis, Experi Autoimm Myasth Gravis, & Syndrome
Neurol 28:130, Lindstrom,J.M., 1978

Myasthenia Gravis
NEJM 298:136, Drachman,D.B., 1978

4-Aminopyridine-A New Drug Tested in the Treatment of Eaton-Lambert Syndrome
JNNP 40:1109, Lundh,H.,et al, 1977

Adverse Effects of Magnesium Salt Cathartics in a Patient with the Myasthenic Syndrome (Lambert-Eaton Syndrome)
Ann Neurol 2:175, Streib,E.W., 1977

Myasthenia Gravis, Study of Humoral Immune Mechanisms by Passive Transfer to Mice
NEJM 296:125, Toyka,K.V.,et al, 1977

Cause of Weakness in Myasthenia Gravis
NEJM 294:722, Grob,D., 1976

Acetylcholine Receptor Antibodies in Myasthenia Gravis
NEJM 293:760, Appel,S.H.,et al, 1975

Neuromuscular Junction in Myasthenia Gravis:Decreased Acetylcholine Receptors
Science 182:293, Fambrough,D.M.,et al, 1973

Multiple Sclerosis Associated with Defects in Neuromuscular Transmission
JNNP 35:385, Patten,B.M.,et al, 1972

Histometric Anal. of Ultra-structure of Neuromuscular Junct. in Myasthenia Gravis & in the Myasthenic Syndr
Ann N Y Acad Sci 186:46, Engel,A.,et al, 1971

Myasthenic Syndrome in Patients with ALS
et al Neurol 9:627, Mulder,D.W., 1959

Risk of False Acetylcholine Receptor Autoantibody Positivity by Radioimmunoprecipitation Assay in Clinical Practice
Neurol 104:e213498, Zara,P.,et al, 2025

The "Chameleon Eyes Sign" in Myasthenia Gravis
Neurol 103:e209756, Zara,P.,et al, 2024

Clinicopathologic Conference, Myasthenia Gravis
NEJM 391:1441-1450, Case 32-2024, 2024

Clinicopathologic Conference, Brain Abscess Due to Infection with Listeria Monocytogeneses
NEJM 391:1529-1538, Case 33-2024, 2024



Showing articles 0 to 50 of 2789 Next >>